JHS Svendgaard Laboratories Limited(IN:JHS)
₹8.19+0.09 (+1.11%)
IN:JHS
JHS Svendgaard Laboratories Limited financials statements
₹8.19
At close:+0.09 (+1.11%)
Want to see IN:JHS full AI Analyst Report?
JHS Svendgaard Laboratories Limited (JHS) Ratios
1 Followers
JHS Svendgaard Laboratories Limited Ratios
IN:JHS's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:JHS's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.95 | 2.18 | 1.87 | 2.31 | 4.18 |
| Quick Ratio | 1.48 | 1.70 | 1.12 | 1.96 | 3.54 |
| Cash Ratio | 0.12 | 0.27 | 0.39 | 1.01 | 0.28 |
| Solvency Ratio | 0.14 | -0.41 | 0.08 | -0.21 | 0.11 |
| Operating Cash Flow Ratio | -0.06 | -0.21 | -0.37 | 0.63 | -0.48 |
| Short-Term Operating Cash Flow Coverage | -0.22 | -1.16 | -2.50 | 166.93 | -44.89 |
| Net Current Asset Value | ₹ 228.75M | ₹ 253.86M | ₹ 164.93M | ₹ 304.56M | ₹ 520.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.03 | 0.03 | 0.07 | 0.03 |
| Debt-to-Equity Ratio | 0.09 | 0.04 | 0.03 | 0.09 | 0.03 |
| Debt-to-Capital Ratio | 0.08 | 0.04 | 0.03 | 0.08 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.07 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.16 | 1.16 | 1.31 | 1.19 |
| Debt Service Coverage Ratio | 0.63 | -2.24 | 0.71 | -15.97 | 2.61 |
| Interest Coverage Ratio | -5.68 | -21.17 | -14.75 | -26.71 | -5.29 |
| Debt to Market Cap | 0.26 | 0.05 | 0.03 | 0.11 | 0.01 |
| Interest Debt Per Share | 1.80 | 0.84 | 0.71 | 2.05 | 1.18 |
| Net Debt to EBITDA | 1.83 | 0.07 | -1.18 | 1.33 | 0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.43% | 33.65% | 29.16% | 19.68% | 23.59% |
| EBIT Margin | -1.41% | -12.98% | -4.25% | -26.65% | 1.75% |
| EBITDA Margin | 5.96% | -4.34% | 4.84% | -19.48% | 9.99% |
| Operating Profit Margin | -4.80% | -13.00% | -8.98% | -17.36% | -8.60% |
| Pretax Profit Margin | -2.25% | -13.60% | -4.91% | -27.29% | 0.12% |
| Net Profit Margin | -1.89% | -21.46% | -5.81% | -20.83% | -4.74% |
| Continuous Operations Profit Margin | -1.89% | -21.46% | -5.81% | -20.83% | -5.02% |
| Net Income Per EBT | 83.93% | 157.86% | 118.35% | 76.34% | -3933.98% |
| EBT Per EBIT | 46.93% | 104.58% | 54.72% | 157.15% | -1.40% |
| Return on Assets (ROA) | -0.89% | -9.81% | -2.06% | -7.68% | -1.83% |
| Return on Equity (ROE) | -1.10% | -11.43% | -2.39% | -10.08% | -2.18% |
| Return on Capital Employed (ROCE) | -2.67% | -6.78% | -3.61% | -7.62% | -3.62% |
| Return on Invested Capital (ROIC) | -2.13% | -6.58% | -3.53% | -5.80% | 149.92% |
| Return on Tangible Assets | -0.90% | -9.98% | -2.10% | -7.70% | -1.83% |
| Earnings Yield | -3.36% | -20.20% | -3.07% | -14.42% | -3.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.07 | 6.96 | 5.00 | 2.79 | 4.72 |
| Payables Turnover | 4.70 | 4.54 | 3.51 | 3.38 | 4.72 |
| Inventory Turnover | 5.54 | 5.14 | 2.83 | 5.20 | 5.40 |
| Fixed Asset Turnover | 1.12 | 1.06 | 0.79 | 1.15 | 1.11 |
| Asset Turnover | 0.47 | 0.46 | 0.35 | 0.37 | 0.39 |
| Working Capital Turnover Ratio | 3.39 | 3.72 | 2.04 | 1.55 | 1.08 |
| Cash Conversion Cycle | 48.43 | 43.13 | 97.96 | 93.09 | 67.65 |
| Days of Sales Outstanding | 60.14 | 52.44 | 73.02 | 130.90 | 77.35 |
| Days of Inventory Outstanding | 65.92 | 71.06 | 129.00 | 70.25 | 67.62 |
| Days of Payables Outstanding | 77.62 | 80.37 | 104.06 | 108.06 | 77.32 |
| Operating Cycle | 126.05 | 123.50 | 202.02 | 201.14 | 144.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.24 | -0.62 | -1.10 | 2.97 | -1.42 |
| Free Cash Flow Per Share | -1.70 | -1.89 | -5.14 | 1.14 | -2.47 |
| Dividend Paid and CapEx Coverage Ratio | -0.16 | -0.49 | -0.27 | 1.62 | -1.36 |
| Capital Expenditure Coverage Ratio | -0.16 | -0.49 | -0.27 | 1.62 | -1.36 |
| Operating Cash Flow Coverage Ratio | -0.14 | -0.80 | -1.67 | 1.50 | -1.48 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.06 | -0.12 | 0.28 | -0.11 |
| Free Cash Flow Yield | -26.02% | -16.08% | -30.33% | 7.36% | -12.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -29.77 | -4.95 | -32.60 | -6.94 | -32.62 |
| Price-to-Sales (P/S) Ratio | 0.56 | 1.06 | 1.89 | 1.45 | 1.55 |
| Price-to-Book (P/B) Ratio | 0.33 | 0.57 | 0.78 | 0.70 | 0.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.84 | -6.22 | -3.30 | 13.59 | -8.33 |
| Price-to-Operating Cash Flow Ratio | -27.30 | -18.87 | -15.41 | 5.22 | -14.47 |
| Price-to-Earnings Growth (PEG) Ratio | 0.33 | -0.01 | 0.43 | -0.03 | 0.08 |
| Enterprise Value Multiple | 11.27 | -24.41 | 37.98 | -6.09 | 15.57 |
| Enterprise Value | 683.32M | 974.35M | 1.28B | 997.75M | 1.33B |
| EV to EBITDA | 11.27 | -24.41 | 37.98 | -6.09 | 15.57 |
| EV to Sales | 0.67 | 1.06 | 1.84 | 1.19 | 1.56 |
| EV to Free Cash Flow | -4.59 | -6.20 | -3.20 | 11.16 | -8.38 |
| EV to Operating Cash Flow | -32.59 | -18.82 | -14.94 | 4.28 | -14.56 |
| Tangible Book Value Per Share | 19.69 | 20.34 | 21.33 | 22.07 | 30.15 |
| Shareholders’ Equity Per Share | 19.99 | 20.73 | 21.77 | 22.17 | 28.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | -0.58 | -0.18 | 0.24 | 42.64 |
| Revenue Per Share | 11.64 | 11.04 | 8.95 | 10.73 | 13.29 |
| Net Income Per Share | -0.22 | -2.37 | -0.52 | -2.23 | -0.63 |
| Tax Burden | 0.84 | 1.58 | 1.18 | 0.76 | -39.34 |
| Interest Burden | 1.60 | 1.05 | 1.16 | 1.02 | 0.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.22 | 0.27 | 0.02 | 0.05 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.09 | 0.41 | 0.56 | -1.01 | -88.70 |
Currency in INR

